Compare TENB & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENB | PBH |
|---|---|---|
| Founded | 2002 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | 2018 | 2005 |
| Metric | TENB | PBH |
|---|---|---|
| Price | $23.52 | $64.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 5 |
| Target Price | $38.12 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 1.5M | 387.7K |
| Earning Date | 02-04-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.04 |
| Revenue | $974,603,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $12.22 | N/A |
| Revenue Next Year | $7.62 | $2.50 |
| P/E Ratio | ★ N/A | $15.82 |
| Revenue Growth | ★ 11.05 | N/A |
| 52 Week Low | $22.51 | $57.25 |
| 52 Week High | $45.45 | $90.04 |
| Indicator | TENB | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 59.79 |
| Support Level | $23.08 | $61.86 |
| Resistance Level | $24.01 | $63.48 |
| Average True Range (ATR) | 0.57 | 1.44 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 31.46 | 76.12 |
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.